Cycloleucine blocks 5'-terminal and internal methylations of avian sarcoma virus genome RNA.
Cycloleucine, a competitive inhibitor of ATP:  L-methionine S-adenosyltransferase in vitro, has been used to reduce intracellular concentrations of S-adenosylmethionine and by this means to inhibit virion RNA methylation in chicken embryo cells that are infected with B77 avian sarcoma virus. Under conditions of cycloleucine treatment, where virus production as measured by incorporation of radioactive precursors or by number of infectious particles is not significantly affected, the internal m6A methylations of the avian sarcoma virus genome RNA are inhibited greater than 90%. The predominant 5'-terminal structure in viral RNA produced by treated cells in m7G(5')pppG (cap zero) rather than m7G-(5')pppGm (cap 1). It appears from these results that internal m6A and penultimate ribose methylations are not required for avian sarcoma RNA synthesis and function. Furthermore, these methylations are apparently not required for transport of genome RNA to virus assembly sites. The insensitivity of the 5'-terminal m7G methylation to inhibition by cycloleucine suggests that the affinity of S-adenosylmethionine for 7-methylguanosine methyltransferase is significantly greater than for the 2'-0-methyltransferases or the N6-methyltransferases.
D000596:Amino Acids / Q000494:pharmacology*; D001358:Avian Sarcoma Viruses / Q000187:drug effects / Q000378:metabolism*; D001483:Base Sequence; D003515:Cycloleucine / Q000494:pharmacology*; D005814:Genes, Viral; D008716:Methionine Adenosyltransferase / Q000037:antagonists & inhibitors; D008745:Methylation; D012367:RNA, Viral / Q000378:metabolism*
D000596:Amino Acids; D012367:RNA, Viral; D003515:Cycloleucine; D008716:Methionine Adenosyltransferase